IR Department, in partnership with Morgans and Stockhead, presents the inaugural HealthInvest 2024 summit at Kittyhawk on Wednesday September 18th, 2024.

With rapid growth and significant success underpinning a strong return in investor interest in the healthcare sector, HealthInvest 2024 will showcase some of Australia’s leading and emerging health and life sciences companies to an audience of professional and retail investors.

This event will provide investors with the chance to hear directly from presenting companies, followed by networking opportunities over a drink and canapés.

Presenting companies and speakers include:

Clarity Pharmaceuticals (ASX: CU6) - Dr Alan Taylor, Executive Chair
ImpediMed (ASX: IPD) - Dr Parmjot Bains, Managing Director, CEO
Imricor Medical Systems (ASX: IMR) - Nick Corkill, Vice President Corporate Strategy
Percheron Therapeutics (ASX: PER) - Dr James Garner, Managing Director & CEO
Race Oncology (ASX: RAC) - Dr Peter Smith, Executive Director